{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:56:38Z","timestamp":1792000598512,"version":"4.4.0"},"reference-count":242,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2015,7,14]],"date-time":"2015-07-14T00:00:00Z","timestamp":1436832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0130733","type":"journal-article","created":{"date-parts":[[2015,7,14]],"date-time":"2015-07-14T18:05:10Z","timestamp":1436897110000},"page":"e0130733","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":246,"title":["A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache"],"prefix":"10.1371","volume":"10","author":[{"given":"Jeffrey L.","family":"Jackson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Cogbill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Santana-Davila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Eldredge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Collier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Gradall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Sehgal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Kuester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,7,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1046\/j.1468-2982.2001.00248.x","article-title":"Epidemiology of headache","volume":"21","author":"BK Rasmussen","year":"2001","journal-title":"Cephalalgia"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s11910-003-0060-7","article-title":"Epidemiology of migraine and other types of headache in Asia","volume":"3","author":"SJ Wang","year":"2003","journal-title":"Current Neurology & Neuroscience Reports"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1526-4610.2008.01263.x","article-title":"Prevalence and burden of headache and migraine in Germany","volume":"49","author":"A Radtke","year":"2009","journal-title":"Headache"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10194-006-0273-7","article-title":"Economic impact of primary headaches in Turkey: a university hospital based study: part II","volume":"7","author":"N Karli","year":"2006","journal-title":"J Headache Pain"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1590\/S0004-282X2010000600008","article-title":"Prevalence and impact of headache in undergraduate students in Southern Brazil","volume":"68","author":"A Falavigna","year":"2010","journal-title":"Arq Neuropsiquiatr"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1046\/j.1468-2982.2003.00543.x","article-title":"The family impact of migraine: population-based studies in the USA and UK","volume":"23","author":"RB Lipton","year":"2003","journal-title":"Cephalalgia"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1468-2982.2003.00546.x","article-title":"Migraine headache disability and health-related quality-of-life: a population-based case-control study from England","volume":"23","author":"RB Lipton","year":"2003","journal-title":"Cephalalgia"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/0333102410381145","article-title":"Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS)","volume":"31","author":"AM Blumenfeld","year":"2011","journal-title":"Cephalalgia"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/j.1526-4610.2010.01770.x","article-title":"Health-related quality of life, disability and severity of disease in patients with migraine attending to a specialty headache center","volume":"50","author":"M Leonardi","year":"2010","journal-title":"Headache"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Raggi A, Leonardi M, Bussone G, D'Amico D (2010) Value and utility of disease-specific and generic instruments for assessing disability in patients with migraine, and their relationships with health-related quality of life. Neurol Sci. doi: 10.1007\/s10072-010-0466-3<\/ext-link><\/comment>","DOI":"10.1007\/s10072-010-0466-3"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1526-4610.2008.01117_1.x","article-title":"A pivotal moment in 50 years of headache history: the first American Migraine Study","volume":"48","author":"SJ Tepper","year":"2008","journal-title":"Headache"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.clinthera.2007.05.008","article-title":"The cycle of migraine: patients' quality of life during and between migraine attacks","volume":"29","author":"FG Freitag","year":"2007","journal-title":"Clin Ther"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/archinte.159.8.813","article-title":"Burden of migraine in the United States: disability and economic costs","volume":"159","author":"XH Hu","year":"1999","journal-title":"Archives of Internal Medicine"},{"key":"ref14","first-page":"S62","article-title":"The cost of migraine and its treatment","volume":"11","author":"LD Goldberg","year":"2005","journal-title":"Am J Manag Care"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1177\/0333102413485658","article-title":"The International Classification of Headache Disorders, 3rd edition (beta version)","volume":"33","year":"2013","journal-title":"Cephalalgia"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Adams AM, Serrano D, Buse DC, Reed ML, Marske V, Fanning KM, et al. (2014) The impact of chronic migraine: The Chronic Migraine Epidemiology and Outcomes (CaMEO) Study methods and baseline results. Cephalalgia. 0333102414552532 [pii]; doi: 10.1177\/0333102414552532<\/ext-link><\/comment>","DOI":"10.1177\/0333102414552532"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Law S, Derry S, Moore RA (2010) Triptans for acute cluster headache. Cochrane Database Syst Rev CD008042. doi: 10.1002\/14651858.CD008042.pub2<\/ext-link><\/comment>","DOI":"10.1002\/14651858.CD008042.pub2"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"McCrory DC, Gray RN (2003) Oral sumatriptan for acute migraine. Cochrane Database Syst Rev CD002915. doi: 10.1002\/14651858.CD002915<\/ext-link><\/comment>","DOI":"10.1002\/14651858.CD002915"},{"key":"ref19","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003226.pub2","article-title":"Anticonvulsant drugs for migraine prophylaxis","author":"E Chronicle","year":"2004"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Linde K, Rossnagel K (2004) Propranolol for migraine prophylaxis. Cochrane Database Syst Rev CD003225. 10.1002\/14651858.CD003225.pub2.","DOI":"10.1002\/14651858.CD003225.pub2"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1001\/jama.2012.505","article-title":"Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis","volume":"307","author":"JL Jackson","year":"2012","journal-title":"JAMA"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"E269","DOI":"10.1503\/cmaj.081657","article-title":"Prophylaxis of migraine headache","volume":"182","author":"T Pringsheim","year":"2010","journal-title":"CMAJ"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.5694\/j.1326-5377.1968.tb27464.x","article-title":"Clinical trial of a new serotonin antagonist, BC105, in the prevention of migraine","volume":"1","author":"JW Lance","year":"1968","journal-title":"Med J Aust"},{"key":"ref24","unstructured":"Moja PL, Cusi C, Sterzi RR, Canepari C (2005) Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches. Cochrane Database Syst Rev CD002919. doi: 10.1002\/14651858.CD002919.pub2<\/ext-link><\/comment>"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"c5222","DOI":"10.1136\/bmj.c5222","article-title":"Tricyclic antidepressants and headaches: systematic review and meta-analysis","volume":"341","author":"JL Jackson","year":"2010","journal-title":"BMJ"},{"key":"ref26","first-page":"S25","article-title":"Recurrent migraine: cost-effective care","volume":"44","author":"AM Rapaport","year":"1994","journal-title":"Neurology"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1212\/WNL.0b013e3182535d20","article-title":"Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society","volume":"78","author":"SD Silberstein","year":"2012","journal-title":"Neurology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s11606-013-2433-1","article-title":"Preventive pharmacologic treatments for episodic migraine in adults","volume":"28","author":"TA Shamliyan","year":"2013","journal-title":"J Gen Intern Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement","volume":"6","author":"D Moher","year":"2009","journal-title":"PLos Med"},{"key":"ref30","first-page":"717","article-title":"Classification of headache","volume":"179","year":"1962","journal-title":"JAMA"},{"key":"ref31","first-page":"1","article-title":"Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain","volume":"8","year":"1988","journal-title":"Cephalalgia"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1468-2982.2008.01555.x","article-title":"Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults","volume":"28","author":"S Silberstein","year":"2008","journal-title":"Cephalalgia"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1097\/00005650-198903001-00015","article-title":"Effect sizes for interpreting changes in health status","volume":"27","author":"LE Kazis","year":"1989","journal-title":"Med Care"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0895-4356(92)90054-Q","article-title":"Variance imputation for overviews of clinical trials with continuous response","volume":"45","author":"D Follmann","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1600-0404.1973.tb01282.x","article-title":"The prophylactic treatment of migraine with an antiserotonin pizotifen","volume":"49","author":"P Hubbe","year":"1973","journal-title":"Acta Neurol Scand"},{"key":"ref36","first-page":"430","article-title":"Data extraction errors in meta-analyses that use standardized mean differences","volume":"298","author":"PC Gotzsche","year":"2007","journal-title":"JAMA"},{"key":"ref37","unstructured":"McCrory D (2012) Report on gabapentin (Neurontin) for migraine prophylaxis: Evaluation of efficacy, effectiveness and marking. Expert Consultant's report."},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1056\/NEJMsa0906126","article-title":"Outcome reporting in industry-sponsored trials of gabapentin for off-label use","volume":"361","author":"SS Vedula","year":"2009","journal-title":"N Engl J Med"},{"key":"ref39","article-title":"Cochrane Reviewers' Handbook 4.2.2","author":"P Alderson","year":"2004"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"AR Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"key":"ref41","unstructured":"Higgins JPT, Green S (2009) Cochrane Handbook for Systematic Reviews of Interventions<\/italic> Version 5.0.2 [updated September 2009]. www.cochrane-handbook.org<\/ext-link>."},{"key":"ref42","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"R DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"issue":"Suppl 1","key":"ref43","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1046\/j.1526-4610.2001.01154-4.x","article-title":"Antiepileptic drugs in migraine prevention","volume":"41","author":"NT Mathew","year":"2001","journal-title":"Headache"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1524-4733.2010.00784.x","article-title":"Network meta-analysis with competing risk outcomes","volume":"13","author":"AE Ades","year":"2010","journal-title":"Value Health"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1002\/sim.1201","article-title":"Network meta-analysis for indirect treatment comparisons","volume":"21","author":"T Lumley","year":"2002","journal-title":"Stat Med"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"G Salanti","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1471-2288-10-54","article-title":"Network meta-analysis on the log-hazard scale, combining count and hazard ratio statistics accounting for multi-arm trials: a tutorial","volume":"10","author":"BS Woods","year":"2010","journal-title":"BMC Med Res Methodol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/sim.4780070807","article-title":"A note on graphical presentation of estimated odds ratios from several clinical trials","volume":"7","author":"RF Galbraith","year":"1988","journal-title":"Statistics in Medicine"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"JP Higgins","year":"2003","journal-title":"BMJ"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1001\/jama.295.6.676","article-title":"Comparison of two methods to detect publication bias in meta-analysis","volume":"295","author":"JL Peters","year":"2006","journal-title":"JAMA"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"M Egger","year":"1997","journal-title":"BMJ"},{"key":"ref52","first-page":"16","article-title":"Meta-analysis regression","volume":"42","author":"S Sharp","year":"1998","journal-title":"Stata Technical Bulletin"},{"key":"ref53","first-page":"587","article-title":"Double blind trial of clonidine in the treatment of migraine in a general practice","volume":"28","author":"EI Adam","year":"1978","journal-title":"J R Coll Gen Pract"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1600-0404.1978.tb02889.x","article-title":"Clonidine in the prophylaxis of migraine","volume":"58","author":"E Boisen","year":"1978","journal-title":"Acta Neurol Scand"},{"key":"ref55","first-page":"153","article-title":"Efficacy of transdermal clonidine for headache prophylaxis and reduction of narcotic use in migraine patients. A randomized crossover trial","volume":"29","author":"RC Bredfeldt","year":"1989","journal-title":"J Fam Pract"},{"key":"ref56","first-page":"149","article-title":"Clonidine in prevention of migraine. Report of a double-blind study of 38 patients referred for neurological assessment","volume":"137","author":"F Lynggaard","year":"1975","journal-title":"Ugeskr Laeger"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1600-0404.1977.tb01448.x","article-title":"Prophylactic treatment of migraine with clonidine. A controlled clinical trial","volume":"56","author":"K Mondrup","year":"1977","journal-title":"Acta Neurol Scand"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1526-4610.1975.hed1503202.x","article-title":"Double blind study of clonidine and placebo for the prophylactic treatment of migraine","volume":"15","author":"RE Ryan Sr","year":"1975","journal-title":"Headache"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1046\/j.1526-4610.2002.02122.x","article-title":"Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study","volume":"42","author":"JR Saper","year":"2002","journal-title":"Headache"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0140-6736(72)90855-0","article-title":"Evaluation of clonidine in prophylaxis of migraine. Double-blind trial and follow-up","volume":"1","author":"J Shafar","year":"1972","journal-title":"Lancet"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1600-0404.1976.tb04343.x","article-title":"Clonidine (Catapresan)-double-blind study after long-term treatment with the drug in migraine","volume":"53","author":"P Stensrud","year":"1976","journal-title":"Acta Neurol Scand"},{"key":"ref62","first-page":"475","article-title":"Captopril versus placebo in the prevention of hemicrania without aura. A randomized double-blind study","volume":"141","author":"S Paterna","year":"1992","journal-title":"Clin Ter"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/bmj.322.7277.19","article-title":"Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study","volume":"322","author":"H Schrader","year":"2001","journal-title":"BMJ"},{"key":"ref64","first-page":"72","article-title":"Efficacy of Enalapril in Migraine Prophylaxis: A Randomized, Double-blind, Placebo-controlled Trial","volume":"4","author":"SA Sonbolestan","year":"2013","journal-title":"Int J Prev Med"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1468-2982.2008.01825.x","article-title":"Telmisartan in migraine prophylaxis: a randomized, placebo-controlled trial","volume":"29","author":"HC Diener","year":"2009","journal-title":"Cephalalgia"},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"Stovner LJ, Linde M, Gravdahl GB, Tronvik E, Aamodt AH, Sand T, et al.(2013) A comparative study of candesartan versus propranolol for migraine prophylaxis: A randomised, triple-blind, placebo-controlled, double cross-over study. Cephalalgia. 0333102413515348 [pii]; doi: 10.1177\/0333102413515348<\/ext-link><\/comment>","DOI":"10.1177\/0333102413515348"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.289.1.65","article-title":"Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial","volume":"289","author":"E Tronvik","year":"2003","journal-title":"JAMA"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1177\/0333102410384886","article-title":"Levetiracetam in chronic daily headache: A double-blind, randomised placebo-controlled study: (The Australian KEPPRA Headache Trial [AUS-KHT])","volume":"31","author":"RG Beran","year":"2011","journal-title":"Cephalalgia"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1001\/jama.291.8.965","article-title":"Topiramate for migraine prevention: a randomized controlled trial","volume":"291","author":"JL Brandes","year":"2004","journal-title":"JAMA"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1526-4610.2008.01326.x","article-title":"Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial","volume":"49","author":"RK Cady","year":"2009","journal-title":"Headache"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1016\/j.clinph.2007.06.060","article-title":"Effects of levetiracetam vs topiramate and placebo on visually evoked phase synchronization changes of alpha rhythm in migraine","volume":"118","author":"M. deTommaso","year":"2007","journal-title":"Clin Neurophysiol"},{"key":"ref72","first-page":"145","article-title":"Gabapentin in the prophylaxis of migraine: a double-blind randomized placebo-controlled study","volume":"151","author":"G Di Trapani","year":"2000","journal-title":"Clin Ter"},{"key":"ref73","first-page":"943","article-title":"Topiramate in migraine prophylaxis\u2014results from a placebo-controlled trial with propranolol as an active control","volume":"251","author":"HC Diener","year":"2004","journal-title":"J Neurol"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1468-2982.2007.01326.x","article-title":"Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study","volume":"27","author":"HC Diener","year":"2007","journal-title":"Cephalalgia"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1017\/S1092852900018733","article-title":"Topiramate in the preventive treatment of episodic migraine: a combined analysis from pilot, double-blind, placebo-controlled trials","volume":"8","author":"KR Edwards","year":"2003","journal-title":"CNS Spectr"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1212\/WNL.58.11.1652","article-title":"A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis","volume":"58","author":"FG Freitag","year":"2002","journal-title":"Neurology"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1358\/mf.1998.20.4.485692","article-title":"Prophylactic sodium valproate therapy in patients with drug-resistant migraine","volume":"20","author":"K Ghose","year":"1998","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1368-5031.2006.0796a.x","article-title":"Topiramate for migraine prophylaxis: addressing the blood-brain barrier-related pharmacokinetic-pathophysiological disconnect","volume":"60","author":"VK Gupta","year":"2006","journal-title":"Int J Clin Pract"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1046\/j.1468-2982.1992.1202081.x","article-title":"Sodium valproate in the prophylactic treatment of migraine: a double-blind study versus placebo","volume":"12","author":"R Hering","year":"1992","journal-title":"Cephalalgia"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1212\/WNL.44.4.647","article-title":"Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebo-controlled crossover study","volume":"44","author":"R Jensen","year":"1994","journal-title":"Neurology"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1468-2982.1997.1702103.x","article-title":"Divalproex sodium in migraine prophylaxis: a dose-controlled study","volume":"17","author":"J Klapper","year":"1997","journal-title":"Cephalalgia"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/0333102410372427","article-title":"Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID study","volume":"31","author":"RB Lipton","year":"2011","journal-title":"Cephalalgia"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/archneur.1995.00540270077022","article-title":"Migraine prophylaxis with divalproex","volume":"52","author":"NT Mathew","year":"1995","journal-title":"Arch Neurol"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/01.WNF.000022888.49044.99","article-title":"Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine","volume":"29","author":"D Mei","year":"2006","journal-title":"Clin Neuropharmacol"},{"key":"ref85","first-page":"75","article-title":"Aetiology of migraine and prevention with carbamazepine (Tegretol): results of a double-blind, cross-over study","volume":"44","author":"H Rompel","year":"1970","journal-title":"S Afr Med J"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.euroneuro.2014.03.010","article-title":"Sodium valproate in migraine without aura and medication overuse headache: a randomized controlled trial","volume":"24","author":"P Sarchielli","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/archneur.61.4.490","article-title":"Topiramate in migraine prevention: results of a large controlled trial","volume":"61","author":"SD Silberstein","year":"2004","journal-title":"Arch Neurol"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.clinthera.2006.07.003","article-title":"Efficacy and tolerability of topiramate 200 mg\/d in the prevention of migraine with\/without aura in adults: a randomized, placebo-controlled, double-blind, 12-week pilot study","volume":"28","author":"SD Silberstein","year":"2006","journal-title":"Clin Ther"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1526-4610.2006.00684.x","article-title":"Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial","volume":"47","author":"SD Silberstein","year":"2007","journal-title":"Headache"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1212\/01.wnl.0000297551.27191.70","article-title":"Oxcarbazepine in migraine headache: a double-blind, randomized, placebo-controlled study","volume":"70","author":"S Silberstein","year":"2008","journal-title":"Neurology"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/0333102412466968","article-title":"Randomized, double-blind, placebo-controlled, phase II trial of gabapentin enacarbil for migraine prophylaxis","volume":"33","author":"S Silberstein","year":"2013","journal-title":"Cephalalgia"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1046\/j.1468-2982.2003.00592.x","article-title":"Topiramate in the treatment of chronic migraine","volume":"23","author":"M Silvestrini","year":"2003","journal-title":"Cephalalgia"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1212\/01.WNL.0000100121.58594.11","article-title":"Gabapentin in the prophylaxis of chronic daily headache: a randomized, placebo-controlled study","volume":"61","author":"PJ Spira","year":"2003","journal-title":"Neurology"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1468-2982.1997.1702109.x","article-title":"Lamotrigine versus placebo in the prophylaxis of migraine with and without aura","volume":"17","author":"TJ Steiner","year":"1997","journal-title":"Cephalalgia"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1526-4610.1979.hed1906333.x","article-title":"Clonazepam (rivotril) in migraine prophylaxis","volume":"19","author":"P Stensrud","year":"1979","journal-title":"Headache"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1046\/j.1526-4610.2001.01190.x","article-title":"Topiramate in migraine prevention: a double-blind, placebo-controlled study","volume":"41","author":"JR Storey","year":"2001","journal-title":"Headache"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/PL00007866","article-title":"Efficacy and tolerability of acetazolamide in migraine prophylaxis: a randomised placebo-controlled trial","volume":"249","author":"K Vahedi","year":"2002","journal-title":"J Neurol"},{"key":"ref98","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/WNF.0000000000000005","article-title":"Levetiracetam in migraine prophylaxis: a randomized placebo-controlled study in a rural medical institute in Northern India","volume":"36","author":"A Verma","year":"2013","journal-title":"Clin Neuropharmacol"},{"key":"ref99","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10194-008-0002-5","article-title":"The effect of sodium valproate on chronic daily headache and its subgroups","volume":"9","author":"VA Yurekli","year":"2008","journal-title":"J Headache Pain"},{"key":"ref100","first-page":"263","article-title":"Propranolol in prophylaxis of migraine","volume":"82","author":"GK Ahuja","year":"1985","journal-title":"Indian J Med Res"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1046\/j.1468-2982.1993.1302128.x","article-title":"Comparison of propranolol LA 80 mg and propranolol LA 160 mg in migraine prophylaxis: a placebo controlled study","volume":"13","author":"HK al-Qassab","year":"1993","journal-title":"Cephalalgia"},{"key":"ref102","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1046\/j.1468-2982.1983.0304207.x","article-title":"Prophylactic treatment of classical and non-classical migraine with metoprolol\u2014a comparison with placebo","volume":"3","author":"PG Andersson","year":"1983","journal-title":"Cephalalgia"},{"key":"ref103","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1600-0404.1974.tb02810.x","article-title":"Prophylactic treatment of migraine with propranolol. A clinical trial","volume":"50","author":"SE Borgesen","year":"1974","journal-title":"Acta Neurol Scand"},{"key":"ref104","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1526-4610.1979.hed1907379.x","article-title":"Timolol in migraine prophylaxis","volume":"19","author":"RS Briggs","year":"1979","journal-title":"Headache"},{"key":"ref105","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/03331024870070S6204","article-title":"No clearcut longterm prophylactic effect of one month of treatment with propranolol in migraineurs","volume":"7","author":"C Dahlof","year":"1987","journal-title":"Cephalalgia"},{"key":"ref106","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1468-2982.1996.1606441.x","article-title":"Cyclandelate in the prophylaxis of migraine: a randomized, parallel, double-blind study in comparison with placebo and propranolol. The Study group","volume":"16","author":"HC Diener","year":"1996","journal-title":"Cephalalgia"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1526-4610.1972.hed1201015.x","article-title":"Clinical trial of LB-46 (d, 1-4-(2-hydroxy-3-isopropylaminopropoxy)indol. An adrenergic beta-receptor blocking agent in migraine prophylaxis","volume":"12","author":"K Ekbom","year":"1972","journal-title":"Headache"},{"key":"ref108","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1526-4610.1975.hed1502129.x","article-title":"Alprenolol for migraine prophylaxis","volume":"15","author":"K Ekbom","year":"1975","journal-title":"Headache"},{"key":"ref109","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1600-0404.1977.tb01423.x","article-title":"Oxprenolol in the treatment of migraine","volume":"56","author":"K Ekbom","year":"1977","journal-title":"Acta Neurol Scand"},{"key":"ref110","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1526-4610.1976.hed1605238.x","article-title":"Propranolol for migraine prophylaxis","volume":"16","author":"B Forssman","year":"1976","journal-title":"Headache"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1526-4610.1983.hed2304188.x","article-title":"Atenolol for migraine prophylaxis","volume":"23","author":"B Forssman","year":"1983","journal-title":"Headache"},{"key":"ref112","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1515\/jom-1984-841214","article-title":"Nadolol and placebo comparison study in the prophylactic treatment of migraine","volume":"84","author":"FG Freitag","year":"1984","journal-title":"J Am Osteopath Assoc"},{"key":"ref113","doi-asserted-by":"crossref","first-page":"c4871","DOI":"10.1136\/bmj.c4871","article-title":"Effect of preventive (beta blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial","volume":"341","author":"KA Holroyd","year":"2010","journal-title":"BMJ"},{"key":"ref114","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1526-4610.1987.hed2707372.x","article-title":"Atenolol in migraine prophylaxis a double-blind cross-over multicentre study","volume":"27","author":"V Johannsson","year":"1987","journal-title":"Headache"},{"key":"ref115","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1600-0404.1986.tb04591.x","article-title":"Comparison of mefenamic acid and propranolol with placebo in migraine prophylaxis","volume":"73","author":"RH Johnson","year":"1986","journal-title":"Acta Neurol Scand"},{"key":"ref116","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1468-2982.1984.0402091.x","article-title":"Metoprolol and propranolol in the prophylactic treatment of classical and common migraine. A double-blind study","volume":"4","author":"P Kangasniemi","year":"1984","journal-title":"Cephalalgia"},{"key":"ref117","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1526-4610.1973.hed1204163.x","article-title":"Propranolol prophylaxis of migraine","volume":"12","author":"BP Malvea","year":"1973","journal-title":"Headache"},{"key":"ref118","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1526-4610.1981.hed2103105.x","article-title":"Prophylaxis of migraine and mixed headache. A randomized controlled study","volume":"21","author":"NT Mathew","year":"1981","journal-title":"Headache"},{"key":"ref119","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1600-0404.1986.tb03299.x","article-title":"Prophylactic treatment of migraine with tolfenamic acid, propranolol and placebo","volume":"73","author":"B Mikkelsen","year":"1986","journal-title":"Acta Neurol Scand"},{"key":"ref120","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1526-4610.1986.hed2604175.x","article-title":"Propranolol in the prophylaxis of migraine","volume":"26","author":"JW Nadelmann","year":"1986","journal-title":"Headache"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1526-4610.1978.hed1801020.x","article-title":"A double blind trial of acebutolol for migraine prophylaxis","volume":"18","author":"RN Nanda","year":"1978","journal-title":"Headache"},{"key":"ref122","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1742-1241.1983.tb08456.x","article-title":"Prophylactic propranolol in the treatment of headache","volume":"37","author":"TG Palferman","year":"1983","journal-title":"Br J Clin Pract"},{"key":"ref123","first-page":"273","article-title":"Propranolol and migraine. A clinical trial","volume":"3","author":"E Pita","year":"1977","journal-title":"Arch Farmacol Toxicol"},{"key":"ref124","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1046\/j.1468-2982.1989.904247.x","article-title":"Long-acting propranolol in migraine prophylaxis: results of a double-blind, placebo-controlled study","volume":"9","author":"A Pradalier","year":"1989","journal-title":"Cephalalgia"},{"key":"ref125","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1526-4610.1985.hed2506320.x","article-title":"A comparison of naproxen sodium to propranolol hydrochloride and a placebo control for the prophylaxis of migraine headache","volume":"25","author":"J Sargent","year":"1985","journal-title":"Headache"},{"key":"ref126","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1600-0404.1972.tb07532.x","article-title":"Clinical trial of a beta-receptor blocking agent (LB 46) in migraine prophylaxis","volume":"48","author":"O Sjaastad","year":"1972","journal-title":"Acta Neurol Scand"},{"key":"ref127","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1468-2982.1982.0203165.x","article-title":"The prophylactic effect of timolol versus propranolol and placebo in common migraine: beta-blockers in migraine","volume":"2","author":"B Standnes","year":"1982","journal-title":"Cephalalgia"},{"key":"ref128","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2524.1988.hed2801015.x","article-title":"Metoprolol in the prophylaxis of migraine: parallel-groups comparison with placebo and dose-ranging follow-up","volume":"28","author":"TJ Steiner","year":"1988","journal-title":"Headache"},{"key":"ref129","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1001\/jama.1984.03350180030025","article-title":"Migraine prevention with timolol. A double-blind crossover study","volume":"252","author":"S Stellar","year":"1984","journal-title":"JAMA"},{"key":"ref130","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1600-0404.1976.tb04342.x","article-title":"Short-term clinical trial of phopranolol in racemic form (Inderal), D-propranolol and placebo in migraine","volume":"53","author":"P Stensrud","year":"1976","journal-title":"Acta Neurol Scand"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1526-4610.1980.h2004006.x","article-title":"Comparative trial of Tenormin (atenolol) and Inderal (propranolol) in migraine","volume":"20","author":"P Stensrud","year":"1980","journal-title":"Headache"},{"key":"ref132","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0404.1984.tb07772.x","article-title":"Timolol vs propranolol vs placebo in common migraine prophylaxis: a double-blind multicenter trial","volume":"69","author":"P Tfelt-Hansen","year":"1984","journal-title":"Acta Neurol Scand"},{"key":"ref133","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1046\/j.1468-2982.1997.1705596.x","article-title":"Prophylactic treatment of migraine with bisoprolol: a placebo-controlled study","volume":"17","author":"LL van de Ven","year":"1997","journal-title":"Cephalalgia"},{"key":"ref134","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1212\/WNL.22.4.366","article-title":"The treatment of migraine with propranolol","volume":"22","author":"RB Weber","year":"1972","journal-title":"Neurology"},{"key":"ref135","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/bmj.2.5921.699","article-title":"Propranolol in the treatment of migraine","volume":"2","author":"TE Wideroe","year":"1974","journal-title":"Br Med J"},{"key":"ref136","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/archneur.1987.00520170016015","article-title":"Migraine prophylaxis. A comparison of propranolol and amitriptyline","volume":"44","author":"DK Ziegler","year":"1987","journal-title":"Arch Neurol"},{"key":"ref137","first-page":"639","article-title":"European multicenter trial of nimodipine in the prophylaxis of classic migraine (migraine with aura)","volume":"29","year":"1989","journal-title":"Migraine-Nimodipine European Study Group (MINES). Headache"},{"key":"ref138","first-page":"633","article-title":"European multicenter trial of nimodipine in the prophylaxis of common migraine (migraine without aura)","volume":"29","year":"1989","journal-title":"Migraine-Nimodipine European Study Group (MINES). Headache"},{"key":"ref139","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1468-2982.1988.0804269.x","article-title":"Nimodipine in migraine prophylaxis","volume":"8","author":"E Ansell","year":"1988","journal-title":"Cephalalgia"},{"key":"ref140","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1526-4610.1983.hed2303106.x","article-title":"Nimodipine, a new calcium antagonist, in the prophylactic treatment of migraine","volume":"23","author":"HJ Gelmers","year":"1983","journal-title":"Headache"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1046\/j.1468-2982.1985.0501039.x","article-title":"Efficacy of nimodipine in the prophylaxis of migraine","volume":"5","author":"H Havanka-Kanniainen","year":"1985","journal-title":"Cephalalgia"},{"key":"ref142","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1468-2982.1990.1003111.x","article-title":"Migraine treatment with nicardipine","volume":"10","author":"M Leandri","year":"1990","journal-title":"Cephalalgia"},{"key":"ref143","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1212\/WNL.34.7.973","article-title":"Verapamil in prophylactic therapy of migraine","volume":"34","author":"HG Markley","year":"1984","journal-title":"Neurology"},{"key":"ref144","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1212\/WNL.39.2.284","article-title":"Nifedipine in the prophylaxis of classic migraine: a crossover, double-masked, placebo-controlled study of headache frequency and side effects","volume":"39","author":"JC McArthur","year":"1989","journal-title":"Neurology"},{"key":"ref145","first-page":"770","article-title":"Nifedipine in migraine and tension headache: a randomised double blind crossover study","volume":"43","author":"R Shukla","year":"1995","journal-title":"J Assoc Physicians India"},{"key":"ref146","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1001\/jama.1983.03340180054025","article-title":"Verapamil prophylaxis of migraine. A double-blind, placebo-controlled study","volume":"250","author":"GD Solomon","year":"1983","journal-title":"JAMA"},{"key":"ref147","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1526-4610.1988.hed2804260.x","article-title":"Effect of prophylactic administration of nimodipine in patients with migraine","volume":"28","author":"DJ Stewart","year":"1988","journal-title":"Headache"},{"key":"ref148","first-page":"169","article-title":"A double-blind trial of flunarizine in migraine prophylaxis","volume":"4","author":"S Diamond","year":"1992","journal-title":"Headache Quarterly"},{"key":"ref149","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0303-8467(84)90273-7","article-title":"Flunarizine, a new preventive approach to migraine. A double-blind comparison with placebo","volume":"86","author":"CW Frenken","year":"1984","journal-title":"Clin Neurol Neurosurg"},{"key":"ref150","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1526-4610.1981.hed2106235.x","article-title":"A double-blind placebo-controlled prophylactic study of flunarizine (Sibelium) in migraine","volume":"21","author":"P Louis","year":"1981","journal-title":"Headache"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1468-2982.1985.0501031.x","article-title":"Flunarizine in the prevention of classical migraine: a placebo-controlled evaluation","volume":"5","author":"G Mendenopoulos","year":"1985","journal-title":"Cephalalgia"},{"key":"ref152","first-page":"27","article-title":"Effectiveness of flunarizine in altering electronystagmographic patterns in migraine patients: a preliminary report","volume":"6","author":"LA Pini","year":"1986","journal-title":"Int J Clin Pharmacol Res"},{"key":"ref153","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1468-2982.1986.0601007.x","article-title":"A placebo-controlled, double-blind, cross-over trial of flunarizine in common migraine","volume":"6","author":"PS Sorensen","year":"1986","journal-title":"Cephalalgia"},{"key":"ref154","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1526-4610.1991.hed3109613.x","article-title":"Flunarizine in migraine prophylaxis: an Indian trial","volume":"31","author":"M Thomas","year":"1991","journal-title":"Headache"},{"key":"ref155","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1526-4610.1992.hed3202101.x","article-title":"Fluoxetine prophylaxis of migraine","volume":"32","author":"C Adly","year":"1992","journal-title":"Headache"},{"key":"ref156","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1046\/j.1526-4610.1999.3910716.x","article-title":"Fluoxetine for migraine prophylaxis: a double-blind trial","volume":"39","author":"CC d'Amato","year":"1999","journal-title":"Headache"},{"key":"ref157","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1046\/j.1526-4610.1999.3901028.x","article-title":"Selective serotonin reuptake inhibitors for migraine prophylaxis","volume":"39","author":"S Landy","year":"1999","journal-title":"Headache"},{"key":"ref158","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1526-4610.1994.hed3409497.x","article-title":"Double-blind trial of fluoxetine: chronic daily headache and migraine","volume":"34","author":"JR Saper","year":"1994","journal-title":"Headache"},{"key":"ref159","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1046\/j.1468-2982.1998.1805283.x","article-title":"S-fluoxetine in the prophylaxis of migraine: a phase II double-blind randomized placebo-controlled study","volume":"18","author":"TJ Steiner","year":"1998","journal-title":"Cephalalgia"},{"key":"ref160","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1600-0404.1981.tb04423.x","article-title":"Femoxetine in the prophylaxis of migraine\u2014a randomised comparison with placebo","volume":"64","author":"I Zeeberg","year":"1981","journal-title":"Acta Neurol Scand"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1526-4610.2005.05029.x","article-title":"The efficacy and safety of venlafaxine in the prophylaxis of migraine","volume":"45","author":"SN Ozyalcin","year":"2005","journal-title":"Headache"},{"key":"ref162","first-page":"5","article-title":"The treatment of migraine with BC 105 (pizotifen): a double blind trial","volume":"73","author":"GP Arthur","year":"1971","journal-title":"N Z Med J"},{"key":"ref163","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1526-4610.1990.hed3011710.x","article-title":"A comparative study of naproxen sodium, pizotyline and placebo in migraine prophylaxis","volume":"30","author":"AJ Bellavance","year":"1990","journal-title":"Headache"},{"key":"ref164","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1185\/03007997509113649","article-title":"Pizotifen (BC 105) in migraine prophylaxis","volume":"3","author":"JD Carroll","year":"1975","journal-title":"Curr Med Res Opin"},{"key":"ref165","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000112899","article-title":"Studies to assess if pizotifen prophylaxis improves migraine beyond the benefit offered by acute sumatriptan therapy alone","volume":"38","author":"PG Cleland","year":"1997","journal-title":"Eur Neurol"},{"key":"ref166","first-page":"63","article-title":"BC 105 in the prophylaxis of migraine","volume":"13","author":"RC Hughes","year":"1971","journal-title":"Curr Ther Res Clin Exp"},{"key":"ref167","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1526-4610.1979.hed1904219.x","article-title":"Placebo, 1-isopropylnoradrenochrome-5-monosemicarbazono and pizotifen in migraine prophylaxis","volume":"19","author":"P Kangasniemi","year":"1979","journal-title":"Headache"},{"key":"ref168","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1526-4610.1977.hed1703109.x","article-title":"Sanomigran for migraine prophylaxis, controlled multicenter trial in general practice","volume":"17","author":"ER Lawrence","year":"1977","journal-title":"Headache"},{"key":"ref169","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1600-0404.1977.tb01405.x","article-title":"A comparison between placebo, pizotifen and 1-isopropyl-3-hydroxy-5-semicarbazono-6-oxo-2.3.5.6-tetrahydroindol (Divascan) in migraine prophylaxis","volume":"56","author":"PO Osterman","year":"1977","journal-title":"Acta Neurol Scand"},{"key":"ref170","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1526-4610.1968.hed0803118.x","article-title":"Double-blind crossover comparison of bc-105, methysergide and placebo in the prophylaxis of migraine headache","volume":"8","author":"RE Ryan","year":"1968","journal-title":"Headache"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1001\/archneur.1979.00500470065013","article-title":"Amitriptyline in migraine prophylaxis","volume":"36","author":"JR Couch","year":"1979","journal-title":"Arch Neurol"},{"key":"ref172","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1526-4610.2010.01800.x","article-title":"Amitriptyline in the prophylactic treatment of migraine and chronic daily headache","volume":"51","author":"JR Couch","year":"2011","journal-title":"Headache"},{"key":"ref173","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1136\/jnnp.36.4.684","article-title":"Amitriptyline in migraine prophylaxis. Changes in pattern of attacks during a controlled clinical trial","volume":"36","author":"JD Gomersall","year":"1973","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref174","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/jnnp.35.4.500","article-title":"A trial of opipramol in the treatment of migraine","volume":"35","author":"H Jacobs","year":"1972","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref175","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1526-4610.1985.hed2502107.x","article-title":"Clomipramine and metoprolol in migraine prophylaxis\u2014a double-blind crossover study","volume":"25","author":"HD Langohr","year":"1985","journal-title":"Headache"},{"key":"ref176","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1526-4610.1979.hed1907382.x","article-title":"Doxepin in the prophylactic treatment of mixed 'vascular' and tension headache","volume":"19","author":"TJ Morland","year":"1979","journal-title":"Headache"},{"issue":"Suppl 3","key":"ref177","first-page":"49","article-title":"Clomipramine in the prevention of migraine","volume":"8","author":"JF Noone","year":"1980","journal-title":"J Int Med Res"},{"key":"ref178","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1600-0404.1980.tb01504.x","article-title":"Propranolol (Inderal) and clonidine (Catapressan) in the prophylactic treatment of migraine. A comparative trial","volume":"61","author":"B Kass","year":"1980","journal-title":"Acta Neurol Scand"},{"key":"ref179","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.1468-2982.1985.0503159.x","article-title":"Metoprolol v. clonidine in the prophylactic treatment of migraine","volume":"5","author":"P Louis","year":"1985","journal-title":"Cephalalgia"},{"key":"ref180","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3109\/00207454.2011.626908","article-title":"A comparative study of the effects of low-dose topiramate versus sodium valproate in migraine prophylaxis","volume":"122","author":"D Afshari","year":"2012","journal-title":"Int J Neurosci"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1526-4610.1989.hed22904215.x","article-title":"Nifedipine versus propranolol for the initial prophylaxis of migraine","volume":"29","author":"GW Albers","year":"1989","journal-title":"Headache"},{"key":"ref182","first-page":"20","article-title":"A comparative efficiency of amitriptyline, fluoxetine and maprotiline in prevention of migraine in attack-free period","volume":"100","author":"AV Amelin","year":"2000","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"key":"ref183","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1526-4610.1973.hed1302068.x","article-title":"BC-105 and deseril in migraine prophylaxis. (A double-blind study)","volume":"13","author":"PG Andersson","year":"1973","journal-title":"Headache"},{"key":"ref184","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1600-0404.1981.tb04407.x","article-title":"Propranolol and femoxetine, a HT-uptake inhibitor, in migraine prophylaxis. A double-blind crossover study","volume":"64","author":"PG Andersson","year":"1981","journal-title":"Acta Neurol Scand"},{"key":"ref185","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1600-0404.2008.01087.x","article-title":"A double-blind, randomized trial of low-dose topiramate vs propranolol in migraine prophylaxis","volume":"118","author":"F Ashtari","year":"2008","journal-title":"Acta Neurol Scand"},{"key":"ref186","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1526-4610.1994.hed3408476.x","article-title":"A comparative study of amitriptyline and fluvoxamine in migraine prophylaxis","volume":"34","author":"J Bank","year":"1994","journal-title":"Headache"},{"key":"ref187","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/01.wnf.0000192136.46145.44","article-title":"Efficacy of topiramate and valproate in chronic migraine","volume":"28","author":"M Bartolini","year":"2005","journal-title":"Clin Neuropharmacol"},{"key":"ref188","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1526-4610.1986.hed2605237.x","article-title":"Prophylaxis of migraine: a comparison between naproxen sodium and pizotifen","volume":"26","author":"PO Behan","year":"1986","journal-title":"Headache"},{"key":"ref189","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1212\/WNL.51.5.1475","article-title":"Long-term outcome of migraine therapy: predictive value of the frontotemporal nitroglycerin test","volume":"51","author":"S Bonuso","year":"1998","journal-title":"Neurology"},{"key":"ref190","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1590\/S0004-282X1997000400003","article-title":"Propranolol vs flunarizine vs flunarizine plus propranolol in migraine without aura prophylaxis. A double-blind trial","volume":"55","author":"CA Bordini","year":"1997","journal-title":"Arq Neuropsiquiatr"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3109\/00207454.2013.765419","article-title":"The effects of cinnarizine versus sodium valproate in migraine prophylaxis","volume":"123","author":"A Bostani","year":"2013","journal-title":"Int J Neurosci"},{"key":"ref192","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.clineuro.2004.03.004","article-title":"Venlafaxine versus amitriptyline in the prophylactic treatment of migraine: randomized, double-blind, crossover study","volume":"107","author":"S Bulut","year":"2004","journal-title":"Clin Neurol Neurosurg"},{"key":"ref193","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1526-4610.2011.02054.x","article-title":"Two Center, Randomized Pilot Study of Migraine Prophylaxis Comparing Paradigms Using Pre-Emptive Frovatriptan or Daily Topiramate: Research and Clinical Implications","volume":"52","author":"RK Cady","year":"2012","journal-title":"Headache"},{"key":"ref194","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1468-2982.1986.0601015.x","article-title":"Flunarizine-pizotifen single-dose double-blind cross-over trial in migraine prophylaxis","volume":"6","author":"R Cerbo","year":"1986","journal-title":"Cephalalgia"},{"key":"ref195","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1468-2982.2002.t01-1-00309.x","article-title":"Efficacy and tolerability in migraine prophylaxis of flunarizine in reduced doses: a comparison with propranolol 160 mg daily","volume":"22","author":"HC Diener","year":"2002","journal-title":"Cephalalgia"},{"key":"ref196","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.clinthera.2009.03.020","article-title":"Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs","volume":"31","author":"DW Dodick","year":"2009","journal-title":"Clin Ther"},{"key":"ref197","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1590\/S0004-282X2009000600002","article-title":"A double-blind randomized controlled trial of low doses of propranolol, nortriptyline, and the combination of propranolol and nortriptyline for the preventive treatment of migraine","volume":"67","author":"RB Domingues","year":"2009","journal-title":"Arq Neuropsiquiatr"},{"key":"ref198","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF00280110","article-title":"Nimodipine in migraine: clinical efficacy and endocrinological effects","volume":"41","author":"R Formisano","year":"1991","journal-title":"Eur J Clin Pharmacol"},{"key":"ref199","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1600-0404.1972.tb07541.x","article-title":"A comparison between BC 105 and methysergide in the prophylaxis of migraine","volume":"48","author":"B Forssman","year":"1972","journal-title":"Acta Neurol Scand"},{"key":"ref200","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1017\/S0317167100041962","article-title":"Comparison of the efficacy and safety of flunarizine to propranolol in the prophylaxis of migraine","volume":"19","author":"MJ Gawel","year":"1992","journal-title":"Can J Neurol Sci"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1468-2982.1991.1101037.x","article-title":"Responders and non-responders to metoprolol, propranolol and nifedipine treatment in migraine prophylaxis: a dose-range study based on time-series analysis","volume":"11","author":"WD Gerber","year":"1991","journal-title":"Cephalalgia"},{"key":"ref202","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1526-4610.2006.00599.x","article-title":"Low-dose topiramate versus lamotrigine in migraine prophylaxis (the Lotolamp study)","volume":"47","author":"P Gupta","year":"2007","journal-title":"Headache"},{"key":"ref203","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1600-0404.1973.tb01282.x","article-title":"The prophylactic treatment of migraine with an antiserotonin pizotifen","volume":"49","author":"P Hubbe","year":"1973","journal-title":"Acta Neurol Scand"},{"key":"ref204","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/ane.12081","article-title":"Amitriptyline vs divalproate in migraine prophylaxis: a randomized controlled trial","volume":"128","author":"J Kalita","year":"2013","journal-title":"Acta Neurol Scand"},{"key":"ref205","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1600-0404.1983.tb04836.x","article-title":"Femoxetine\u2014a new 5-HT uptake inhibitor\u2014and propranolol in the prophylactic treatment of migraine","volume":"68","author":"PJ Kangasniemi","year":"1983","journal-title":"Acta Neurol Scand"},{"key":"ref206","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1001\/archneur.1997.00550210071015","article-title":"A comparison of divalproex with propranolol and placebo for the prophylaxis of migraine without aura","volume":"54","author":"RG Kaniecki","year":"1997","journal-title":"Arch Neurol"},{"key":"ref207","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.clineuro.2008.05.025","article-title":"A double-blind randomized controlled trial of topiramate and amitriptyline either alone or in combination for the prevention of migraine","volume":"110","author":"K Keskinbora","year":"2008","journal-title":"Clin Neurol Neurosurg"},{"key":"ref208","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1046\/j.1526-4610.2002.02125.x","article-title":"Amitriptyline versus amitriptyline combined with fluoxetine in the preventative treatment of transformed migraine: a double-blind study","volume":"42","author":"AV Krymchantowski","year":"2002","journal-title":"Headache"},{"key":"ref209","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10194-011-0395-4","article-title":"Topiramate plus nortriptyline in the preventive treatment of migraine: a controlled study for nonresponders","volume":"13","author":"AV Krymchantowski","year":"2012","journal-title":"J Headache Pain"},{"key":"ref210","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1468-2982.1982.0204197.x","article-title":"Comparison of flunarizine (Sibelium) and pizotifen (Sandomigran) in migraine treatment: a double-blind study","volume":"2","author":"P Louis","year":"1982","journal-title":"Cephalalgia"},{"issue":"Suppl 8","key":"ref211","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/03331024880080S805","article-title":"Flunarizine vs. propranolol in the prophylaxis of migraine: two double-blind comparative studies in more than 400 patients","volume":"8","author":"CH Lucking","year":"1988","journal-title":"Cephalalgia"},{"key":"ref212","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1526-4610.1989.hed22904219.x","article-title":"Flunarizine and propranolol in the treatment of migraine","volume":"29","author":"HP Ludin","year":"1989","journal-title":"Headache"},{"key":"ref213","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1526-4637.2011.01295.x","article-title":"A randomized, one-year clinical trial comparing the efficacy of topiramate, flunarizine, and a combination of flunarizine and topiramate in migraine prophylaxis","volume":"13","author":"N Luo","year":"2012","journal-title":"Pain Med"},{"key":"ref214","first-page":"267","article-title":"Valproate versus flunarizine in migraine prophylaxis: a randomized, double-open, clinical trial","volume":"12","author":"DD Mitsikostas","year":"1997","journal-title":"Funct Neurol"},{"key":"ref215","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/WNF.0b013e318225140c","article-title":"Zonisamide versus topiramate in migraine prophylaxis: a double-blind randomized clinical trial","volume":"34","author":"SE Mohammadianinejad","year":"2011","journal-title":"Clin Neuropharmacol"},{"key":"ref216","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1526-4610.1986.hed2610490.x","article-title":"Nadolol and propranolol in migraine management","volume":"26","author":"B Olerud","year":"1986","journal-title":"Headache"},{"key":"ref217","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1600-0404.1984.tb00815.x","article-title":"Metoprolol and propranolol in migraine prophylaxis: a double-blind multicentre study","volume":"70","author":"JE Olsson","year":"1984","journal-title":"Acta Neurol Scand"},{"key":"ref218","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1600-0404.1971.tb07504.x","article-title":"BC 105 and methysergide (Deseril) in migraine prophylaxis","volume":"47","author":"J Presthus","year":"1971","journal-title":"Acta Neurol Scand"},{"key":"ref219","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000080960","article-title":"Evaluation of the prophylactic efficacy of amitriptyline and citalopram, alone or in combination, in patients with comorbidity of depression, migraine, and tension-type headache","volume":"50","author":"L Rampello","year":"2004","journal-title":"Neuropsychobiology"},{"key":"ref220","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1526-4610.1986.hed2602083.x","article-title":"Flunarizine versus pizotifen: a double-blind study in the prophylaxis of migraine","volume":"26","author":"A Rascol","year":"1986","journal-title":"Headache"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/0002-8703(84)90600-8","article-title":"Comparative study of nadolol and propranolol in prophylactic treatment of migraine","volume":"108","author":"RE Ryan Sr","year":"1984","journal-title":"Am Heart J"},{"key":"ref222","first-page":"139","article-title":"Dihydroergotamine vs Flunarizine vs Nifedipine vs Metoprolol vs Propranolol in migraine prophylaxis: a comparitive study based on time series analysis","author":"E Scholz","year":"1987"},{"key":"ref223","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1526-4610.2006.00413.x","article-title":"Comparison of the effect of topiramate and sodium valporate in migraine prevention: a randomized blinded crossover study","volume":"46","author":"V Shaygannejad","year":"2006","journal-title":"Headache"},{"key":"ref224","first-page":"75","article-title":"A comparative trial of flunarizine and propranolol in the prevention of migraine","volume":"77","author":"CJ Shimell","year":"1990","journal-title":"S Afr Med J"},{"key":"ref225","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1526-4610.1991.hed3110650.x","article-title":"Flunarizine versus metoprolol in migraine prophylaxis: a double-blind, randomized parallel group study of efficacy and tolerability","volume":"31","author":"PS Sorensen","year":"1991","journal-title":"Headache"},{"key":"ref226","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1526-4610.1987.hed2708421.x","article-title":"Comparative efficacy of nadolol and propranolol in the management of migraine","volume":"27","author":"A Sudilovsky","year":"1987","journal-title":"Headache"},{"key":"ref227","first-page":"43","article-title":"Fluvoxamine, amitriptyline and transcranial electrostimulation of the brain in the treatment of chronic daily headache","volume":"108","author":"SV Tarasova","year":"2008","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"key":"ref228","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10194-008-0044-8","article-title":"Cinnarizine in refractory migraine prophylaxis: efficacy and tolerability. A comparison with sodium valproate","volume":"9","author":"M Togha","year":"2008","journal-title":"J Headache Pain"},{"key":"ref229","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1468-2982.1985.0501017.x","article-title":"Metoprolol and pizotifen in the prophylactic treatment of classical and common migraine. A double-blind investigation","volume":"5","author":"S Vilming","year":"1985","journal-title":"Cephalalgia"},{"key":"ref230","first-page":"3","article-title":"Comparison of efficacy and safety of topiramate with gabapentin in migraine prophylaxis: randomized open label control trial","volume":"63","author":"S Zain","year":"2013","journal-title":"J Pak Med Assoc"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/jcbfm.1995.63","article-title":"D2 receptor blockade by flunarizine and cinnarizine explains extrapyramidal side effects. A SPECT study","volume":"15","author":"T Brucke","year":"1995","journal-title":"J Cereb Blood Flow Metab"},{"issue":"Suppl 3","key":"ref232","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1097\/00005344-199200193-00015","article-title":"Clinical equivalence of once-daily administration of a modified-release formulation of isradipine and twice-daily administration of the standard formulation. Multicentre Study Group","volume":"19","author":"D Holmes","year":"1992","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref233","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1001\/jamapediatrics.2013.508","article-title":"Pharmacological Treatment of Pediatric Headaches: A Meta-analysis","volume":"167","author":"K El-Chammas","year":"2013","journal-title":"JAMA Pediatr"},{"key":"ref234","doi-asserted-by":"crossref","unstructured":"Chronicle E, Mulleners W (2004) Anticonvulsant drugs for migraine prophylaxis. Cochrane Database Syst Rev CD003226.","DOI":"10.1002\/14651858.CD003226.pub2"},{"key":"ref235","doi-asserted-by":"crossref","unstructured":"Linde K, Rossnagel K (2004) Propranolol for migraine prophylaxis. Cochrane Database Syst Rev CD003225.","DOI":"10.1002\/14651858.CD003225.pub2"},{"key":"ref236","doi-asserted-by":"crossref","unstructured":"Mulleners WM, McCrory DC, Linde M (2014) Antiepileptics in migraine prophylaxis: An updated Cochrane review. Cephalalgia. 0333102414534325 [pii]; doi: 10.1177\/0333102414534325<\/ext-link><\/comment>","DOI":"10.1177\/0333102414534325"},{"key":"ref237","doi-asserted-by":"crossref","first-page":"c5222","DOI":"10.1136\/bmj.c5222","article-title":"Tricyclic antidepressants and headaches: systematic review and meta-analysis","volume":"341","author":"JL Jackson","year":"2010","journal-title":"BMJ"},{"key":"ref238","first-page":"54","article-title":"Treatment of chronic headache with antidepressants: a meta-analysis","volume":"111","author":"GE Tomkins","year":"2001","journal-title":"Am J Med"},{"key":"ref239","doi-asserted-by":"crossref","unstructured":"Moja PL, Cusi C, Sterzi RR, Canepari C (2005) Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches. Cochrane Database Syst Rev CD002919.","DOI":"10.1002\/14651858.CD002919.pub2"},{"key":"ref240","doi-asserted-by":"crossref","first-page":"E269","DOI":"10.1503\/cmaj.081657","article-title":"Prophylaxis of migraine headache","volume":"182","author":"T Pringsheim","year":"2010","journal-title":"CMAJ"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1212\/WNL.26.2.121","article-title":"Amitriptyline in the prophylaxis of migraine. Effectiveness and relationship of antimigraine and antidepressant effects","volume":"26","author":"JR Couch","year":"1976","journal-title":"Neurology"},{"key":"ref242","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1526-4610.1971.hed110106.x","article-title":"BC-105 a new preparation for the interval treatment of migraine\u2014a double blind evaluation compared with a placebo","volume":"11","author":"RE Ryan","year":"1971","journal-title":"Headache"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0130733","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T23:50:30Z","timestamp":1717977030000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0130733"}},"subtitle":[],"editor":[{"given":"Oscar","family":"Arias-Carrion","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,7,14]]},"references-count":242,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,7,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0130733","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,14]]}}}